Spanish Society of Hospital Pharmacy position paper on biosimilar medicines
Biological medicines nowadays have a great impact, as they offer treatment for diverse diseases and suppose a high cost for health system. Biosimilar medicines contain a version of an active substance already authorized as an original biotechnological medicine, whose patent has expired, and they c...
Main Authors: | Noemí Martínez-López de Castro, María Belén Matilla-Fernández, María Dolores Fraga-Fuentes, Irene Mangues-Bafalluy, Rocío Asensi-Díez, Gerardo Cajaraville-Ordoñana |
---|---|
Format: | Article |
Language: | English |
Published: |
Grupo Aula Médica
2018-07-01
|
Series: | Farmacia Hospitalaria |
Subjects: | |
Online Access: | http://www.aulamedica.es/fh/pdf/10973.pdf |
Similar Items
-
Knowledge and Perception of Iraqi Pharmacists Towards Biosimilar Medicines
by: Ashwaq J. Mohammed, et al.
Published: (2021-06-01) -
Biosimilars and implications for pharmacy practice: Ready or not, here they come!
by: Hobbs AL, et al.
Published: (2019-09-01) -
Knowledge, Attitude, and Practice Towards Biosimilars and Interchangeable Products: A Prescriptive Insight by the Pharmacists
by: Shakeel S, et al.
Published: (2020-11-01) -
Considerations for the US health-system pharmacist in a world of biosimilars
by: Andrea Zlatkus, et al.
Published: (2020-02-01) -
Biosimilars in rheumatology and other fields of medicine
by: Marcin Milchert, et al.
Published: (2014-07-01)